SMAD3-INHIBITOREN
European patent · EP3833664 · In force
Register entry
- Publication number
- EP3833664
- Application number
- EP19846801
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Aug 6, 2019
- Published
- Jun 16, 2021
- Granted
- May 13, 2026
- Protection ends at the latest
- Aug 5, 2039
- Next annual fee due
- Aug 31, 2027
- IPC classes
- C07D 471/04 (2006.01)C07D 487/04 (2006.01)A61P 35/00 (2006.01)A61K 31/5377 (2006.01)A61K 31/5025 (2006.01)A61K 31/519 (2006.01)A61K 31/352 (2006.01)A61K 31/437 (2006.01)A61K 31/496 (2006.01)A61K 45/06 (2006.01)
- Priority
- US 201862715120 P 06.08.2018
- PCT application
- PCT/CN2019/099521 06.08.2019
- PCT publication
- WO2020/029980 13.02.2020
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.08.2026 → 31.08.2027
Published in Swissreg on 01.09.2026
- Aug 19, 2026
Change
Published in Swissreg on 19.08.2026
- Aug 3, 2026
Agent entered
- Representative
- Natoli Intellectual Property Operations GmbH, Alemannengasse 63, 4058 Basel
Published in Swissreg on 03.08.2026
- May 13, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 13.05.2026
Parties
Inventor
LO, Ho Yin
Bethel, CT 06801, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.